- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A Nicorette presentation slide claimed “no statistically significant difference” vs varenicline, but the study wasn’t powered for that comparison. A footnote didn’t…
HCP complained Richter Resource Centre was disguised promotion and accessible to the public. Panel found no disguised promotion/public advertising, but ruled breaches…
Anonymous employee alleged Astellas misled PMCPA about Milan advisory board delegate selection. Panel/Appeal Board found false/incomplete information and dismissive senior messaging. Result:…
AstraZeneca’s global Twitter account re-tweeted a US disease-awareness post linking to HFSA events. Complaint alleged multiple Code breaches, but the Panel found…
Corporate product pages naming POMs and indications were accessible to the public without clear audience separation or public reference info. PMCPA ruled…
Health professional said Jinarc training site was promotional, lacked clear PI and implied MHRA endorsement. Panel found it was MHRA-mandated risk-minimisation training…
GSK Consumer Healthcare’s NiQuitin 21mg Clear Patch leavepiece compared nicotine delivery vs rival patches. Panel found it could imply clinical superiority without…
Intercompany complaint about Jext leavepiece diagrams and the claim “designed to be easy to use”. Panel found the diagrams aligned with the…
Anonymous complaint alleged reps used litmus paper and eye drops to demonstrate pH and encouraged instillation into eyes. Panel found no evidence…
Vifor’s Ferinject leavepiece used a strapline implying special merit and clinic-time comparison graphics based on altered SPC timings. PMCPA ruled two breaches…
A Xamiol application video was inadvertently included on a Biogen Idec Tysabri patient DVD distributed to HCPs and patients. Leo was held…
A GP alleged a pre-licence sponsored article used an unconfirmed linagliptin price to bypass advance notification rules. The Panel found the article…
PMCPA case AUTH/3068/9/18 (Director v Sanofi) concerned clinical trial disclosure but was ruled outwith the scope of the ABPI Code (2016). No…
PMCPA case AUTH/3083/9/18 (Director v Eisai) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
A shingles awareness advert in a lifestyle magazine, plus links/QR code to a company site and a patient organisation site, was ruled…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.